News

GCC S.A.B. de C.V.: Upcoming Q3 Earnings Call Details

GCC S.A.B. de C.V.: Upcoming Q3 Earnings Call Details

GCC's Third Quarter Earnings Call Announcement

GCC, S.A.B. de C.V. (BMV: GCC*), recognized as a key player in cement and concrete production across the United States and Mexico, is gearing up to host a pivotal conference call. This call is set to discuss the results of their earnings for the third quarter of 2024. The discussion will take place on a Wednesday morning, and those interested in attending can mark their calendars. The projected time for the conference call is 11:00 a.m. (ET), providing stakeholders with insights into the company's performance.

Details on Conference Call Participation

Leading this informative session will be the company’s CEO, Enrique Escalante, along with CFO Maik Strecker. They will share valuable insights and detailed analysis of the company's financial results during the call. Interested participants can join the conversation by dialing +1 (877) 407 0789 for calls in the U.S. or +1 (201) 689 8562 for international inquiries. It’s important to note that the conference ID to access the call is 13743118, ensuring smooth entry into the session.

Accessing the Earnings Presentation

Alongside the live telephone discussion, GCC will provide a presentation and a listen-only webcast. This presentation is a great opportunity for investors and analysts to get a better understanding of the underlying financial metrics. The link to access the webcast will be available on the company's website, further contributing to transparency and investor relations.

Replay and Additional Information

For those who may miss the live session, a recording of the conference call will be made available just a few hours post-event, at 3:00 p.m. (ET) the same day. This recording will remain accessible until the end of the month, allowing ample time for thorough review by stakeholders. The replay can be accessed using the same conference ID number mentioned before for easy retrieval. Additionally, GCC plans to publish an online replay on their official website two days after the live event, promoting continuous engagement. Stakeholders looking to connect directly with stakeholders for more information can reach out to GCC’s Investor Relations.

GCC's Corporate Insights

GCC stands at the forefront of the construction materials industry, producing not only cement but also aggregates and concrete. With an impressive annual cement production capacity reaching 6 million metric tons, they serve a diverse range of markets in both Mexico and the U.S. Established back in 1941, GCC continues to hold a significant position in its industry, with shares actively traded on the Mexican Stock Exchange under the ticker symbol GCC*.

Contacting GCC Investor Relations

For further inquiries regarding the earnings call or company operations, stakeholders are encouraged to connect with Sahory Ogushi, a key representative in GCC’s Investor Relations department. He can be reached at +52 (614) 442 3176 in Mexico or +1 (303) 739 5943 in the U.S. For email communication, Sahory can be contacted at soguship@gcc.com. This straightforward communication channel ensures that all investor queries are addressed in a timely manner.

Frequently Asked Questions

When is the GCC Q3 2024 earnings call?

The earnings call will take place on Wednesday at 11:00 a.m. (ET).

How can I participate in the earnings call?

Participants can dial +1 (877) 407 0789 or +1 (201) 689 8562 for international calls.

Is there a replay of the conference call available?

Yes, a replay will be available the same day at 3:00 p.m. (ET) until the end of the month.

What is GCC known for?

GCC is recognized as a leading producer of cement, concrete, and other construction materials in the U.S. and Mexico.

Who can I contact for more information about GCC?

Sahory Ogushi from Investor Relations can be contacted for inquiries. His details are listed above.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

YONDELIS: Thai Approval Opens New Sarcoma Treatment Path

Updated Category News Views 62

New Hope for Thai Sarcoma Patients Alright, we’ve got some good news coming out of Thailand, folks. The Thai FDA just greenlit YONDELIS® (trabectedin) for those grappling with advanced soft tissue sarcoma (STS). Now, this isn’t your everyday drug release—it’s a clinical chess move packing potential for patients who’ve run out of other options. December 1st,...

Continue Reading
JOYEE N01 Debuts Globally with First 2,000 Deliveries

Updated Category News Views 271

JOYYE N01 Breaks into the Global Market Now, here we go, folks—a Chinese car with ambitions bigger than the Sahara. On October 28, the JOYEE N01 rolled off the assembly line and into the international scene with a lot of fanfare at FAW's Yancheng Branch. Mark my words, this isn't just another model trying to strut into the global auto arena. This event delivered the...

Continue Reading
EZaccessMD Data Breach: Class Action Lawsuit Looms

Updated Category News Views 718

Data breaches are the bogeyman no one wants lurking in the shadows, and when it’s your personal info at stake, folks rightfully squirm. This recent fiasco at EZaccessMD is one of those unsettling incidents. The word on the street isn't pretty: sensitive medical data has slipped through the cracks, leaving Edelson Lechtzin LLP, a heavyweight in class action maneuvers, to...

Continue Reading
Viking Ventures: Impacts of VK2735 on Obesity Examined

Updated Category News Views 135

Viking Therapeutics Reveal Surprising Data on VK2735 The latest from Viking Therapeutics' camp is giving obesity some serious food for thought, with new data making waves at the ObesityWeek® 2026 meeting. Their investigational dual agonist, VK2735, seems to be shaking things up, as early phase clinical data shows an impressive 74% of participants managed to improve at...

Continue Reading
Ambrosia Biosciences Unveils Promising Nonclinical Metabolic Data

Updated Category News Views 255

Ambrosia's Latest Nonclinical Revelations Ambrosia Biosciences has just thrown out some major bait at ObesityWeek® 2026. The highlight? New nonclinical data profiles for two of their understudy small molecule programs—AMB-895 and AMB-131. It may sound niche, but in this sector, promising data spins heads. Their GLP-1 receptor agonist, AMB-895, and GIP receptor...

Continue Reading
Shenzhen's Vision Unveiled: APEC 2026 Promo Debut

Updated Category News Views 410

Shenzhen's Spotlight Moment at APEC 2026 When Shenzhen announced its promotional video for the 2026 APEC Economic Leaders' Meeting, it wasn't just about standard tourism glitz. This was a show of force, a bold step onto the main stage of global politics and economics. The video's launch wasn’t merely an audio-visual delight—it staked a claim in shaping the future...

Continue Reading
CVS Study: GLP-1 Drugs Effective But Costly

Updated Category News Views 105

Can GLP-1s Deliver Value at Their Current Price? Alright, folks, here's a real-world gut check from CVS Health. They crunched some numbers using Aetna's anonymized claims data, and the results are eye-opening. These GLP-1s are showing promising health outcomes—lower hospital visits, better clinical results, yada yada. But when it comes to savings, they ain't quite...

Continue Reading
D-Wave Quantum Hit with Securities Fraud Lawsuit

Updated Category News Views 325

A Legal Quagmire for D-Wave Quantum Investors Securities fraud lawsuits are like light in a dark alley—you need them when the truth's been stashed out of sight, but they illuminate the dirty and damp parts of investment strategies nobody wants to talk about. Right now, D-Wave Quantum Inc. is smack dab in the middle of such litigious action. If you had the misfortune of...

Continue Reading
IDEAYA's IDE101: A New Front in Cancer Battle

Updated Category News Views 139

IDEAYA's Bold Move in Precision Medicine IDEAYA Biosciences, no stranger to the frontlines of cancer treatment, is gunning for a breakthrough with their latest pick, IDE101. They're jumping into the ring with a potential first-in-class inhibitor targeting CDKN2A-deficiency—a notorious player in the solid tumor game. They're not just mixing things up for the sake of it;...

Continue Reading
KINGRVER Boosts RV Comfort with New Water Heater Lineup

Updated Category News Views 190

An Upgrade for the Open Road In the land of RV living, comfort is king—or in this case, KINGRVER. Dropping affordable upgrades for water heaters into the world of RVs, KINGRVER's CT6 lineup is like a warm hug on a chilly campsite morning. Whether you've pulled up to a wooded retreat or parked under the vast desert sky, having dependable hot water shouldn't be a gamble....

Continue Reading

Top 5 Most Recently Viewed Articles

IONQ Achieves Record Stock Levels Amid Strong Growth Indicators

Updated Category News Views 243

IONQ Stock Reaches New Heights Recently, IONQ has made headlines as its stock skyrocketed to an unprecedented level of $47.41, marking a significant achievement for the company. With a robust market capitalization of $10.2 billion, this remarkable performance is a testament to the company's impressive growth trajectory and the strong belief investors hold in its future....

Continue Reading
Model 1 Commercial Vehicles Expands Leadership Team for Growth

Updated Category News Views 285

Model 1 Commercial Vehicles Announces Leadership Changes Model 1 Commercial Vehicles is thrilled to unveil a set of key leadership appointments aimed at enhancing its strategic direction and ensuring the company's ongoing success. These changes reflect the impressive growth trajectory the company has experienced over the past few years. Tony Matijevich Takes the Helm as...

Continue Reading
Texas Instruments: Unusual Options Trends Uncovered

Updated Category News Views 195

Texas Instruments Options Insights Financial powerhouses have made a notable bullish move on Texas Instruments. Our analysis reveals intriguing trends within the options market for Texas Instruments (NASDAQ: TXN), showcasing an unusual number of trades that pinpoint shifting market sentiments. Trading Sentiment Overview Diving deeper into the data, it appears that 58% of...

Continue Reading
SMCP Unveils Latest Interim Financial Report for 2025

Updated Category News Views 177

SMCP Announces Availability of Its Interim Financial Report SMCP is excited to share that its interim financial report for the six-month period ending June 30, 2025, is now available for public access. This report has been officially filed with the relevant regulatory authorities. Details on the Financial Report This financial report outlines the company's performance...

Continue Reading
Kevin O'Leary Discusses Business Leaders' Support for Trump

Updated Category News Views 159

Understanding O'Leary's Perspective on Business Leadership Kevin O’Leary, a prominent entrepreneur and investor from Shark Tank, has provided insight into the evolving relationship between business leaders and President Trump. In recent discussions, O’Leary emphasized that the admiration many tech CEOs and corporate leaders have for Trump is not solely about his tax...

Continue Reading